A multidimensional approach to the elimination of tuberculosis

Author:

Singh NehaORCID,Bhange Khushboo

Abstract

Significant global efforts have been made in recent years to combat tuberculosis (TB) disease. Despite the fact that social and economic causes of TB have been well known for decades, the range of interventions has, until recently, been mostly restricted to the health domain. Mycobacterium tuberculosis that causes tuberculosis, the second-deadliest infectious killer (after COVID-19), which typically damages the lungs. It can spread when TB patients cough or otherwise release bacteria into the air, which can spread the disease. To ensure that significant gaps in outcome-oriented research are recognized and filled, we must promote collaboration among all involved parties in tuberculosis research and control in order to optimise the impact of fundamental research. Consequently, a multisectoral and interdisciplinary strategy is necessary as the global health community works toward the pledges and goals established in two recent high-level political gatherings.

Publisher

MedCrave Group Kft.

Subject

General Materials Science

Reference17 articles.

1. Tuberculosis;Pai;Nat Rev Dis Primers,2016

2. Prasad R, Singh A, Balasubramanian V, et al. Extensively Drug-Resistant Tuberculosis in India: Current Evidence on Diagnosis & Management. Indian J Med Res. 2017;145(3):271-293.

3. Rapid Diagnosis of MDR and XDR Tuberculosis with the MeltPro TB Assay in China;Pang;Sci Rep,2016

4. Seung KJ, Keshavjee S, Michael LR. Multidrug-Resistant Tuberculosis and Extensively Drug-Resistant Tuberculosis. Cold Spring Harb Perspect Med. 2015;5(9):a017863.

5. Tiberi S, Utjesanovic N, Galvin J, et al. Drug Resistant TB - Latest Developments in Epidemiology, Diagnostics and Management. Int J Infect Dis. 2022; S1201-9712(22)00165-5.

Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. A TB free India is far away;Journal of Bacteriology & Mycology: Open Access;2024

2. Pulmonary aspergillosis: infection, diagnosis and treatment;Journal of Bacteriology & Mycology: Open Access;2023

3. Absence of new antibiotics in the world and presence of drug resistant TB in India;Journal of Bacteriology & Mycology: Open Access;2023

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3